$571 Million is the total value of SECTOR GAMMA AS's 27 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 11.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LLY | Sell | LILLY ELI & CO | $60,910,000 | -15.5% | 824,450 | -9.9% | 10.66% | -22.0% |
BAX | Buy | BAXTER INTL INC | $51,393,000 | +5.3% | 1,079,233 | +0.0% | 9.00% | -2.9% |
ABT | Buy | ABBOTT LABS | $34,781,000 | +102.8% | 872,590 | +100.0% | 6.09% | +87.1% |
BMY | Buy | BRISTOL MYERS SQUIBB CO | $32,003,000 | +132.1% | 608,190 | +224.4% | 5.60% | +114.0% |
PKI | Buy | PERKINELMER INC | $31,922,000 | +12.0% | 615,428 | +13.2% | 5.59% | +3.3% |
IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $27,801,000 | +20.2% | 1,960,548 | +10.8% | 4.87% | +10.8% |
BSX | Sell | BOSTON SCIENTIFIC CORP | $27,658,000 | -16.2% | 1,254,880 | -11.1% | 4.84% | -22.7% |
GILD | New | GILEAD SCIENCES INC | $27,009,000 | – | 364,990 | +100.0% | 4.73% | – |
IART | Sell | INTEGRA LIFESCIENCES HLDGS C | $24,010,000 | -8.7% | 306,207 | -7.1% | 4.20% | -15.8% |
VRTX | Sell | VERTEX PHARMACEUTICALS INC | $22,376,000 | -6.8% | 268,880 | -3.7% | 3.92% | -14.1% |
BIO | Buy | BIO RAD LABS INCcl a | $22,351,000 | +21.0% | 132,584 | +2.7% | 3.91% | +11.6% |
MASI | Buy | MASIMO CORP | $21,541,000 | +16.5% | 356,223 | +1.2% | 3.77% | +7.4% |
BIIB | Sell | BIOGEN IDEC INC | $21,107,000 | -9.7% | 71,400 | -26.2% | 3.70% | -16.8% |
EXEL | Sell | EXELIXIS INC | $19,906,000 | +23.7% | 1,610,491 | -21.8% | 3.48% | +14.1% |
MRK | Buy | MERCK & CO INC NEW | $19,097,000 | +33.9% | 318,010 | +28.4% | 3.34% | +23.4% |
MCK | Buy | MCKESSON CORP | $17,710,000 | +20.1% | 131,660 | +66.6% | 3.10% | +10.7% |
PDCO | Sell | PATTERSON COMPANIES INC | $16,138,000 | -19.2% | 345,792 | -17.0% | 2.82% | -25.5% |
ANTM | Buy | ANTHEM INC | $15,171,000 | +10.7% | 122,850 | +17.8% | 2.66% | +2.1% |
SHPG | Sell | SHIRE PLCsponsored adr | $14,245,000 | -49.2% | 84,461 | -44.6% | 2.49% | -53.2% |
CI | Buy | CIGNA CORPORATION | $14,149,000 | +0.6% | 112,070 | +2.0% | 2.48% | -7.2% |
MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $10,644,000 | +7.7% | 958,879 | +4.8% | 1.86% | -0.7% |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $9,979,000 | +16.0% | 83,474 | +2.8% | 1.75% | +7.0% |
LPNT | New | LIFEPOINT HEALTH INC | $9,973,000 | – | 164,714 | +100.0% | 1.75% | – |
IPXL | Buy | IMPAX LABORATORIES INC | $7,318,000 | +8.5% | 409,964 | +75.2% | 1.28% | +0.1% |
OMI | Buy | OWENS & MINOR INC NEW | $6,745,000 | -10.8% | 211,172 | +4.4% | 1.18% | -17.8% |
THC | Buy | TENET HEALTHCARE CORP | $4,996,000 | -7.4% | 252,080 | +29.1% | 0.88% | -14.6% |
SPPI | SPECTRUM PHARMACEUTICALS INC | $268,000 | -44.7% | 73,810 | 0.0% | 0.05% | -48.9% | |
STJ | Exit | ST JUDE MED INC | $0 | – | -258,214 | -100.0% | -3.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
PERKINELMER INC | 33 | Q2 2021 | 6.3% |
BIOGEN INC | 30 | Q3 2023 | 7.6% |
ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-05 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-12 |
13F-HR/A | 2023-02-08 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-09 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-06 |
13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.